
Fable Therapeutics is a biotechnology company operating at the intersection of machine learning and metabolic disease. They aim to improve the lives of millions suffering from obesity and related conditions by advancing a pipeline of biologics targeting validated pathways. Their unique approach harnesses AI to rapidly design enhanced therapeutics, utilizing an ML-guided protein design platform to access challenging target sequences and engineer biomedicines with expanded therapeutic potential. Fable is transforming drug discovery and the treatment of metabolic diseases by creating purpose-built proteins with optimized potency, developability, and binding affinity.

Fable Therapeutics is a biotechnology company operating at the intersection of machine learning and metabolic disease. They aim to improve the lives of millions suffering from obesity and related conditions by advancing a pipeline of biologics targeting validated pathways. Their unique approach harnesses AI to rapidly design enhanced therapeutics, utilizing an ML-guided protein design platform to access challenging target sequences and engineer biomedicines with expanded therapeutic potential. Fable is transforming drug discovery and the treatment of metabolic diseases by creating purpose-built proteins with optimized potency, developability, and binding affinity.